Back to search
FDAFDA · Food and drugs·Recall number Z-1442-2022

NanoSight NS300

Published August 10, 2022 · Recall initiated: April 7, 2022

Summary

FDA records medical device Class II recall Z-1442-2022, published August 10, 2022 and initiated April 7, 2022. Recalling firm: MALVERN PANALYTICAL LTD; Status: Ongoing; Reported quantity: 507 units; Lot: CDRH accession #0510530-003. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product found to not comply to Class 1 Laser safety requirement.

What to do

FDA Mandated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
MALVERN PANALYTICAL LTD
Distributor
US Nationwide - Worldwide Distribution
Lot
CDRH accession #0510530-003
Risk classification
Class II
Area (FDA)
device
Country
United Kingdom

Related recalls

Questions about this recall

Was NanoSight NS300 recalled?

Yes. FDA published recall Z-1442-2022 on August 10, 2022. Reported hazard: Product found to not comply to Class 1 Laser safety requirement.

What should I do if I have this product?

FDA Mandated · Letter